<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28076625</article-id><article-id pub-id-type="pmc">5407140</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160091</article-id><article-categories><subj-group subj-group-type="heading"><subject>Special Article</subject></subj-group></article-categories><title-group><article-title>Endoscopic or No-Touch Vein Harvesting for CABG: What is Best for the
Patient?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kopjar</surname><given-names>Tomislav</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ivankovic</surname><given-names>Stjepan</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lima</surname><given-names>Melchior Luiz</given-names></name><degrees>MD, MSc, PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Pinheiro</surname><given-names>Bruno Botelho</given-names></name><degrees>MD, MSc</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Dashwood</surname><given-names>Michael Richard</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label> Department of Cardiac Surgery, University Hospital
Centre Zagreb, Zagreb, Croatia.</aff><aff id="aff2"><label>2</label> Department of Cardiovascular Surgery, Meridional
Hospital, Vitoria, ES, Brazil.</aff><aff id="aff3"><label>3</label> Department of Cardiovascular Surgery, Clinicord, Anis
Rassi Hospital, Goiania, GO, Brazil.</aff><aff id="aff4"><label>4</label> Surgical and Interventional Sciences, Royal Free
Hospital Campus, University College Medical School, London, United Kingdom.</aff><author-notes><corresp id="c1">Correspondence Address: Michael R Dashwood, Surgical and
Interventional Sciences, Royal Free Hospital Campus, University College Medical
School, Pond Street - London, UK - NW3 2PF. E-mail:
<email>m.dashwood@ucl.ac.uk</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2016</year></pub-date><volume>31</volume><issue>6</issue><fpage>461</fpage><lpage>464</lpage><history><date date-type="received"><day>06</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>17</day><month>10</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup width="50%" span="1"><col span="1"/><col span="1"/></colgroup><thead><tr style="background-color:#e6e7e8"><th colspan="2" align="left" rowspan="1"><bold>Abbreviations, acronyms &#x00026;
symbols</bold></th></tr></thead><tbody><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">=Coronary artery bypass surgery</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">EACTS</td><td align="left" rowspan="1" colspan="1">=European Association for Cardio-Thoracic Surgery</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">ESC</td><td align="left" rowspan="1" colspan="1">=European Society of Cardiology</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">EVH</td><td align="left" rowspan="1" colspan="1">=Endoscopic vein harvesting</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">ISMICS</td><td align="left" rowspan="1" colspan="1">=International Society of Minimally Invasive Cardiothoracic
Surgery</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">ITA</td><td align="left" rowspan="1" colspan="1">=Internal thoracic artery</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">OVH</td><td align="left" rowspan="1" colspan="1">=Open vein harvesting</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">SV</td><td align="left" rowspan="1" colspan="1">=Saphenous vein</td></tr></tbody></table></table-wrap><p>The saphenous vein (SV) is the most commonly used conduit for coronary artery bypass
surgery (CABG)<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>, with minimally invasive endoscopic vein harvesting (EVH)
being used in the majority of CABG in the USA<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>]</sup>. While the benefits of EVH include reduced
wound complications and improved cosmetic outcome, an inferior patency rate of EVH-SVs
compared to those harvested by open vein harvesting (OVH) has been
reported<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup> (<xref ref-type="fig" rid="f1">Figure 1</xref>).
Previous guidance in the United Kingdom advised that EVH should only be used with
special arrangements<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>. This decision was based on data from the Project of
Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV trial, where EVH-SV grafts
showed higher failure rates than OVH grafts and, at 3 years, a higher death rate,
myocardial infarction or revascularization compared to OVH grafts<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>. Originally, the PREVENT IV
trial was designed as a randomized controlled trial to assess the effectiveness and
safety of edifoligide on angiographic SV graft failure 12-18 months following CABG, as
well as the effect of edifoligide on major adverse cardiac events throughout 5 years
after CABG. Considering that the study by Lopes et al.<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup> is a secondary analysis, the
results should be evaluated carefully and potential biases inherent to a non-randomized
study design should be considered. However, data published subsequently included more
patients and, although it was judged that "EVH did not show increased occlusion rates or
incidences of reintervention, myocardial infarction or death for endoscopically
harvested grafts...the Committee noted the importance of training and regular experience
for any clinician doing this procedure" (United Kingdom NICE interventional procedure
guidance 494, 2014)<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>. Simultaneously, the 2014 Guideline on Myocardial
Revascularization of the European Society of Cardiology (ESC) and the European
Association for Cardio-Thoracic Surgery (EACTS) acknowledged the lack of unequivocal
evidence concerning patency rates of EVH-SVs and no inferiority in clinical outcomes
associated with EVH<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Examples of no-touch and endoscopic vein harvesting (EVH) techniques. <bold>A
&#x02013;</bold> Schematic drawing of the long incisions (red) at calf and thigh
for exposure of saphenous vein (SV) (blue) by the no-touch technique.
<bold>B &#x02013;</bold> Schematic drawing of the small incisions (red) made at
levels of upper thigh (~0.4 cm), knee (~3 cm) and ankle (~0.4 cm) using EVH
system. <bold>A1 &#x02013;</bold> Surgery photograph at the surface of the heart
(right atrioventricular sulcus) showing the SV graft stripped of
perivascular adipose tissue (PVAT) remaining intact when removed from the
leg by no-touch technique. <bold>B1 &#x02013;</bold> Surgery photograph at the
surface of the heart (right atrioventricular sulcus) showing the SV graft
stripped of PVAT when removed from the leg by EVH system. <bold>A2 &#x02013;</bold>
Histological photograph of a SV segment, harvested by the no-touch
technique, with preserved PVAT. The histology shows an intact endothelium
lining intima (I) of the lumen (L) and normal appearance of the tunica media
(TM), adventitia (Adv), vasa vasorum (VV) and perivascular adipose tissue
(PVAT). <bold>B2 &#x02013;</bold> Histological photograph of a SV segment, harvested
by the EVH technique, with total removal of PVAT. The histology shows
regions of endothelial denudation and damage to the intima (I), tunica media
(TM) and adventitial (Adv).</p></caption><graphic xlink:href="rbccv-31-06-0461-g01"/></fig>
</p><p>The unfavorable results regarding EVH-SV grafts are due to vascular damage inflicted
where they are subjected to vascular trauma, including traction, adventitial stripping,
and venous compression. Rousou et al.<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup> showed endothelial damage in EVH-SV grafts and
demonstrated that cellular metabolic activity, viability and membrane damage to the
endothelium is less in OVH compared with EVH grafts. Also, using optical coherence
tomography, Kiani &#x00026; Poston<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup> described marked damage to the adventitia of EVH-SV
grafts as well as regions of endothelial denudation and abnormalities within the intima
and deeper vessel layers, damage likely to affect graft patency.</p><p>At the time that EVH was described, an atraumatic, no-touch technique of harvesting the
SV was introduced that, for up to 16 years, provides a superior graft with a patency
rate comparable to the internal thoracic artery (ITA)<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>,</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup>. This data is supported by a recent
randomized trial from the Swedish group, which compared no-touch SV patency to the
radial artery, providing further evidence for the superiority of no-touch SV
grafts<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>.
This is important given the general consensus amongst cardiac surgeons that radial
artery patency is superior and therefore the second conduit of choice. While the
incidence of wound complications in patients receiving no-touch SV is higher than in
those receiving EVH grafts, they are similar to patients receiving OVH grafts and their
performance is far superior, at ~90% <italic>vs.</italic> 50% long-term. Several studies
have reported SV graft failure rates of up to 10% to 20% after 1 year and an additional
5% failure rate for each subsequent year with conventional OVH<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>,</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>-</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup>. When performing OVH, the recent 2014 ESC/EACTS
Guidelines on myocardial revascularization support the use of the notouch technique to
reduce graft injury and improve patency<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>. There is evidence that the improved patency of
no-touch SV over conventional OVH grafts is associated with a reduction in vascular
damage<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup>,
maintaining normal vessel architecture, preservation of an intact
endothelium<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>,</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup> and endotheliumderived NO<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>, as well as preservation
of the <italic>vasa vasorum</italic><sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>,</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup> and the SVs surrounding cushion of perivascular
fat<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>,</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>. The damage inflicted to the SV using both OVH and EVH
affects both short- and long-term graft performance. For example, reduced luminal nitric
oxide availability, due to endothelial injury, leads to increased platelet aggregation,
thrombus formation and early graft occlusion<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>. The results of the immunohistochemical
analysis with CD34, iNOS and three isoforms of nitric oxide synthase in the human SV
removed conventionally showed an evident impairment of the endothelial
function<sup>[</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>-</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup>. Damage to the outer layers of the SV, in particular
the adventitial <italic>vasa vasorum</italic>, reduces transmural blood flow, resulting
in medial ischemia, conditions that have been shown to promote neointimal hyperplasia
and atherosclerosis, thereby affecting mid- and long-term graft
patency<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup>. The cushion of perivascular fat that remains intact
using no-touch technique is an important source of adipocyte-derived vasodilator
factors, suggested to play an important role in preventing venospasm at harvesting and
post implantation<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>. In addition, this pronounced outermost layer of fat
prevents kinking of excessively long grafts and provides mechanical support that
protects the vein once it is subjected to arterial hemodynamics at completion of distal
anastomoses and removal of arterial clamps<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>-</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>.</p><p>Considering the dramatic improvement reported for notouch SV grafts, it is surprising
that this technique is limited to a few cardiac centers, mainly in Sweden and Brazil
and, at a rough estimate, amount to less than 1000 cases per year worldwide. The reasons
for this low take up rate are unclear, but may be associated with senior surgeons'
resistance to change and/or unwillingness to "retrain", rather surprising given the
rapid adoption of EVH to a present level of over 80% of all CABG in the
USA<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup>.
EVH was recommended (Class I, Level A) to reduce wound-related complications, improve
patient satisfaction, and decrease postoperative pain, hospital length of stay, and
outpatient wound-management resources when compared with OVH<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>. While wound complications
are reduced using EVH compared with OVH and no-touch-harvested SVs, graft performance of
EVH grafts may be inferior<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>. Early no-touch SV harvest site complications have been
reported to range from 11% to 18%<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>, considerably higher when compared to EVH, although
similar to conventional OVH<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>. Furthermore, the learning curve for EVH is
longer<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup>,
and although it has been suggested that EVH is a cost effective method for harvesting
the SV, the 2005 Consensus Statement of the International Society of Minimally Invasive
Cardiothoracic Surgery (ISMICS) concluded there was inadequate cost-effectiveness data
to allow recommendations on the resource implications of OVH vs. EVH
techniques<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>. Several recommendation statements and guidelines have
emphasized the importance of experience when performing EVH<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>,</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>. Interestingly, although EVH may reduce
wound complications, the recent study by Te Kolste et al.<sup>[</sup><sup><xref rid="r26" ref-type="bibr">26</xref></sup><sup>]</sup> describes aspects of acute
compartment syndrome, a rare, but serious, limb-threatening condition that may occur
after CABG, especially following EVH. It is noteworthy that, over 10 years ago in their
excellent review, Shuhaiber et al.<sup>[</sup><sup><xref rid="r27" ref-type="bibr">27</xref></sup><sup>]</sup> stated "In the operating room, tissue manipulation
and the role of the surgeon or surgical assistant is quite essential. The no-touch
technique of handling tissues during harvesting should be adopted in order to preserve
the endothelial integrity and function."</p><p>EVH is becoming popular in patients undergoing CABG in Brazil, a situation most likely
influenced by the low wound healing complications and improved cosmetic outcome
associated with this technique, in addition to its favored use in the USA. When
considering the extra cost and problems regarding EVH-SV graft performance as described
above, should the patient be made aware of the potential benefits of no-touch SV grafts?
Should the benefits of no-touch SV harvesting be discussed and should the patient be
given a choice?</p><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup width="50%" span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Authors' roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TK</td><td align="left" rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">SI</td><td align="left" rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">MLL</td><td align="left" rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">BBP</td><td align="left" rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">MRD</td><td align="left" rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr></tbody></table></table-wrap></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest</p></fn><fn fn-type="other"><p>This study was carried out at the Surgical and Interventional Sciences, Royal
Free Hospital Campus, University College Medical School, London, United
Kingdom.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldea</surname><given-names>GS</given-names></name><name><surname>Bakaeen</surname><given-names>FG</given-names></name><name><surname>Pal</surname><given-names>J</given-names></name><name><surname>Fremes</surname><given-names>S</given-names></name><name><surname>Head</surname><given-names>SJ</given-names></name><name><surname>Sabik</surname><given-names>J</given-names></name><etal/></person-group><article-title>The Society of Thoracic Surgeons Clinical Practice Guidelines on
Arterial Conduits for Coronary Artery Bypass Grafting</article-title><source>Ann Thorac Surg</source><year>2016</year><volume>101</volume><issue>2</issue><fpage>801</fpage><lpage>809</lpage><pub-id pub-id-type="pmid">26680310</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name><name><surname>Brennan</surname><given-names>JM</given-names></name><name><surname>Sedrakyan</surname><given-names>A</given-names></name><name><surname>Tavris</surname><given-names>D</given-names></name><name><surname>Alexander</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Association between endoscopic vs open vein-graft harvesting and
mortality, wound complications, and cardiovascular events in patients
undergoing CABG surgery</article-title><source>JAMA</source><year>2012</year><volume>308</volume><issue>5</issue><fpage>475</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">22851114</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopjar</surname><given-names>T</given-names></name><name><surname>Dashwood</surname><given-names>MR</given-names></name></person-group><article-title>Endoscopic Versus"No-Touch" Saphenous Vein Harvesting for
Coronary Artery Bypass Grafting: A Trade-Off Between Wound Healing and Graft
Patency</article-title><source>Angiology</source><year>2016</year><volume>67</volume><issue>2</issue><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">25972395</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dashwood</surname><given-names>MR</given-names></name></person-group><source>Endoscopic saphenous vein harvest for coronary artery bypass
grafting</source><publisher-name>NICE interventional procedure guidance 494</publisher-name><comment>guidanceniceorguk/ipg494</comment><year>2014</year></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>RD</given-names></name><name><surname>Hafley</surname><given-names>GE</given-names></name><name><surname>Allen</surname><given-names>KB</given-names></name><name><surname>Ferguson</surname><given-names>TB</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name><name><surname>Harrington</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Endoscopic versus open vein-graft harvesting in coronary-artery
bypass surgery</article-title><source>N Engl J Med</source><year>2009</year><volume>361</volume><issue>3</issue><fpage>235</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">19605828</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolh</surname><given-names>P</given-names></name><name><surname>Windecker</surname><given-names>S</given-names></name><name><surname>Alfonso</surname><given-names>F</given-names></name><name><surname>Collet</surname><given-names>JP</given-names></name><name><surname>Cremer</surname><given-names>J</given-names></name><name><surname>Falk</surname><given-names>V</given-names></name><etal/></person-group><article-title>2014 ESC/ EACTS Guidelines on myocardial revascularization: the
Task Force on Myocardial Revascularization of the European Society of
Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery
(EACTS). Developed with the special contribution of the European Association
of Percutaneous Cardiovascular Interventions (EAPCI)</article-title><source>Eur J Cardiothorac Surg</source><year>2014</year><volume>46</volume><issue>4</issue><fpage>517</fpage><lpage>592</lpage><pub-id pub-id-type="pmid">25173601</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousou</surname><given-names>LJ</given-names></name><name><surname>Taylor</surname><given-names>KB</given-names></name><name><surname>Lu</surname><given-names>XG</given-names></name><name><surname>Healey</surname><given-names>N</given-names></name><name><surname>Crittenden</surname><given-names>MD</given-names></name><name><surname>Khuri</surname><given-names>SF</given-names></name><etal/></person-group><article-title>Saphenous vein conduits harvested by endoscopic technique exhibit
structural and functional damage</article-title><source>Ann Thorac Surg</source><year>2009</year><volume>87</volume><issue>1</issue><fpage>62</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">19101270</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiani</surname><given-names>S</given-names></name><name><surname>Poston</surname><given-names>R</given-names></name></person-group><article-title>Is endoscopic harvesting bad for saphenous vein graft patency in
coronary surgery</article-title><source>Curr Opin Cardiol</source><year>2011</year><volume>26</volume><issue>6</issue><fpage>518</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">21986399</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>DS</given-names></name><name><surname>Johansson</surname><given-names>B</given-names></name><name><surname>Bojo</surname><given-names>L</given-names></name><name><surname>Karlsson</surname><given-names>R</given-names></name><name><surname>Geijer</surname><given-names>H</given-names></name><name><surname>Filbey</surname><given-names>D</given-names></name><etal/></person-group><article-title>Harvesting the saphenous vein with surrounding tissue for CABG
provides long-term graft patency comparable to the left internal thoracic
artery: results of a randomized longitudinal trial</article-title><source>J Thorac Cardiovasc Surg</source><year>2006</year><volume>132</volume><issue>2</issue><fpage>373</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">16872965</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samano</surname><given-names>N</given-names></name><name><surname>Geijer</surname><given-names>H</given-names></name><name><surname>Liden</surname><given-names>M</given-names></name><name><surname>Fremes</surname><given-names>S</given-names></name><name><surname>Bodin</surname><given-names>L</given-names></name><name><surname>Souza</surname><given-names>D</given-names></name></person-group><article-title>The notouch saphenous vein for coronary artery bypass grafting
maintains a patency, after 16 years, comparable to the left internal
thoracic artery: A randomized trial</article-title><source>J Thorac Cardiovasc Surg</source><year>2015</year><volume>150</volume><issue>4</issue><fpage>880</fpage><lpage>888</lpage><pub-id pub-id-type="pmid">26282605</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dreifaldt</surname><given-names>M</given-names></name><name><surname>Mannion</surname><given-names>JD</given-names></name><name><surname>Bodin</surname><given-names>L</given-names></name><name><surname>Olsson</surname><given-names>H</given-names></name><name><surname>Zagozdzon</surname><given-names>L</given-names></name><name><surname>Souza</surname><given-names>D</given-names></name></person-group><article-title>The no-touch saphenous vein as the preferred second conduit for
coronary artery bypass grafting</article-title><source>Ann Thorac Surg</source><year>2013</year><volume>96</volume><issue>1</issue><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">23684156</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman</surname><given-names>S</given-names></name><name><surname>Zadina</surname><given-names>K</given-names></name><name><surname>Moritz</surname><given-names>T</given-names></name><name><surname>Ovitt</surname><given-names>T</given-names></name><name><surname>Sethi</surname><given-names>G</given-names></name><name><surname>Copeland</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Long-term patency of saphenous vein and left internal mammary
artery grafts after coronary artery bypass surgery: results from a
Department of Veterans Affairs Cooperative Study</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>44</volume><issue>11</issue><fpage>2149</fpage><lpage>2156</lpage><pub-id pub-id-type="pmid">15582312</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>RC</given-names></name><name><surname>Nazarian</surname><given-names>SM</given-names></name><name><surname>Gluckman</surname><given-names>TJ</given-names></name><name><surname>Schulman</surname><given-names>SP</given-names></name><name><surname>Thiemann</surname><given-names>DR</given-names></name><name><surname>Shapiro</surname><given-names>EP</given-names></name><etal/></person-group><article-title>Relative importance of patient, procedural and anatomic risk
factors for early vein graft thrombosis after coronary artery bypass graft
surgery</article-title><source>J Cardiovasc Surg (Torino)</source><year>2011</year><volume>52</volume><issue>6</issue><fpage>877</fpage><lpage>885</lpage></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halabi</surname><given-names>AR</given-names></name><name><surname>Alexander</surname><given-names>JH</given-names></name><name><surname>Shaw</surname><given-names>LK</given-names></name><name><surname>Lorenz</surname><given-names>TJ</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>Kong</surname><given-names>DF</given-names></name><etal/></person-group><article-title>Relation of early saphenous vein graft failure to outcomes
following coronary artery bypass surgery</article-title><source>Am J Cardiol</source><year>2005</year><volume>96</volume><issue>9</issue><fpage>1254</fpage><lpage>1259</lpage><pub-id pub-id-type="pmid">16253593</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsui</surname><given-names>JC</given-names></name><name><surname>Dashwood</surname><given-names>MR</given-names></name></person-group><article-title>Recent strategies to reduce vein graft occlusion: a need to limit
the effect of vascular damage</article-title><source>Eur J Vasc Endovasc Surg</source><year>2002</year><volume>23</volume><issue>3</issue><fpage>202</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">11914005</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>VF</given-names></name><name><surname>Ishigai</surname><given-names>MM</given-names></name><name><surname>Freym&#x000fc;ller</surname><given-names>E</given-names></name><name><surname>Branco</surname><given-names>JN</given-names></name><name><surname>Gaia</surname><given-names>DF</given-names></name><name><surname>Gabriel</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Microscopic and ultrastructural evaluation of the saphenous vein
endothelium for CABG prepared by the no touch technique</article-title><source>Rev Bras Cir Cardiovasc</source><year>2008</year><volume>23</volume><issue>3</issue><fpage>323</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">19082319</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsui</surname><given-names>JC</given-names></name><name><surname>Souza</surname><given-names>DS</given-names></name><name><surname>Filbey</surname><given-names>D</given-names></name><name><surname>Bomfim</surname><given-names>V</given-names></name><name><surname>Dashwood</surname><given-names>MR</given-names></name></person-group><article-title>Preserved endothelial integrity and nitric oxide synthase in
saphenous vein grafts harvested by a 'no-touch'technique</article-title><source>Br J Surg</source><year>2001</year><volume>88</volume><issue>9</issue><fpage>1209</fpage><lpage>1215</lpage><pub-id pub-id-type="pmid">11531869</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dashwood</surname><given-names>MR</given-names></name><name><surname>Anand</surname><given-names>R</given-names></name><name><surname>Loesch</surname><given-names>A</given-names></name><name><surname>Souza</surname><given-names>DS</given-names></name></person-group><article-title>Hypothesis: a potential role for the vasa vasorum in the
maintenance of vein graft patency</article-title><source>Angiology</source><year>2004</year><volume>55</volume><issue>4</issue><fpage>385</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">15258684</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dreifaldt</surname><given-names>M</given-names></name><name><surname>Souza</surname><given-names>DS</given-names></name><name><surname>Loesch</surname><given-names>A</given-names></name><name><surname>Muddle</surname><given-names>JR</given-names></name><name><surname>Karlsson</surname><given-names>MG</given-names></name><name><surname>Filbey</surname><given-names>D</given-names></name><etal/></person-group><article-title>The "no-touch" harvesting technique for vein grafts in coronary
artery bypass surgery preserves an intact vasa vasorum</article-title><source>J Thorac Cardiovasc Surg</source><year>2011</year><volume>141</volume><issue>1</issue><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">20381817</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dashwood</surname><given-names>MR</given-names></name><name><surname>Dooley</surname><given-names>A</given-names></name><name><surname>Shi-Wen</surname><given-names>X</given-names></name><name><surname>Abraham</surname><given-names>DJ</given-names></name><name><surname>Souza</surname><given-names>DS</given-names></name></person-group><article-title>Does periadventitial fat-derived nitric oxide play a role in
improved saphenous vein graft patency in patients undergoing coronary artery
bypass surgery</article-title><source>J Vasc Res</source><year>2007</year><volume>44</volume><issue>3</issue><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">17308436</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dashwood</surname><given-names>MR</given-names></name><name><surname>Tsui</surname><given-names>JC</given-names></name></person-group><article-title>'No-touch' saphenous vein harvesting improves graft performance
in patients undergoing coronary artery bypass surgery: a journey from
bedside to bench</article-title><source>Vascul Pharmacol</source><year>2013</year><volume>58</volume><issue>3</issue><fpage>240</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">22967905</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viaro</surname><given-names>F</given-names></name><name><surname>Carlotti</surname><given-names>CG</given-names><suffix>Jr</suffix></name><name><surname>Rodrigues</surname><given-names>AJ</given-names></name><name><surname>Vicente</surname><given-names>WV</given-names></name><name><surname>Bassetto</surname><given-names>S</given-names></name><name><surname>Reis</surname><given-names>GS</given-names></name><etal/></person-group><article-title>Endothelium dysfunction caused by acute pressure distension of
human saphenous vein used for myocardial revascularization</article-title><source>Rev Bras Cir Cardiovasc</source><year>2007</year><volume>22</volume><issue>2</issue><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">17992321</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tineli</surname><given-names>RA</given-names></name><name><surname>Viaro</surname><given-names>F</given-names></name><name><surname>Dalio</surname><given-names>MB</given-names></name><name><surname>Reis</surname><given-names>GS</given-names></name><name><surname>Basseto</surname><given-names>S</given-names></name><name><surname>Vicente</surname><given-names>WV</given-names></name><etal/></person-group><article-title>Mechanical forces and human saphenous veins: coronary artery
bypass graft implications</article-title><source>Rev Bras Cir Cardiovasc</source><year>2007</year><volume>22</volume><issue>1</issue><fpage>87</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">17992309</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viaro</surname><given-names>F</given-names></name><name><surname>Capellini</surname><given-names>VK</given-names></name><name><surname>Celotto</surname><given-names>AC</given-names></name><name><surname>Carlotti</surname><given-names>CG</given-names><suffix>Jr</suffix></name><name><surname>Rodrigues</surname><given-names>AJ</given-names></name><name><surname>Reis</surname><given-names>GS</given-names></name><etal/></person-group><article-title>Immunohistochemical evaluation of three nitric oxide synthase
isoforms in human saphenous vein exposed to different degrees of distension
pressures</article-title><source>Cardiovasc Pathol</source><year>2010</year><volume>19</volume><issue>6</issue><fpage>e211</fpage><lpage>e220</lpage><pub-id pub-id-type="pmid">20060328</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Cohn</surname><given-names>W</given-names></name><name><surname>Connolly</surname><given-names>M</given-names></name><name><surname>Edgerton</surname><given-names>J</given-names></name><name><surname>Falk</surname><given-names>V</given-names></name><etal/></person-group><article-title>Endoscopic Vascular Harvest in Coronary Artery Bypass Grafting
Surgery: A Consensus Statement of the International Society of Minimally
Invasive Cardiothoracic Surgery (ISMICS) 2005</article-title><source>Innovations (Phila)</source><year>2005</year><volume>1</volume><issue>2</issue><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">22436545</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Te Kolste</surname><given-names>HJ</given-names></name><name><surname>Balm</surname><given-names>R</given-names></name><name><surname>de Mol</surname><given-names>B</given-names></name></person-group><article-title>Acute Compartment Syndrome of the Lower Leg after Coronary Artery
Bypass Grafting: A Silent but Dangerous Complication</article-title><source>Thorac Cardiovasc Surg</source><year>2015</year><volume>63</volume><issue>4</issue><fpage>300</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">25602845</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuhaiber</surname><given-names>JH</given-names></name><name><surname>Evans</surname><given-names>AN</given-names></name><name><surname>Massad</surname><given-names>MG</given-names></name><name><surname>Geha</surname><given-names>AS</given-names></name></person-group><article-title>Mechanisms and future directions for prevention of vein graft
failure in coronary bypass surgery</article-title><source>Eur J Cardiothorac Surg</source><year>2002</year><volume>22</volume><issue>3</issue><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">12204729</pub-id></element-citation></ref></ref-list></back></article>